OncoSec Medical, Inc.
(NASDAQ : ONCS)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
...
Commercial Services » Miscellaneous Commercial Services
symbolcompany%chnglast%shortavg$volume
FLTFleetCor Technologies, Inc. 0.35%310.043.4%$254.74m
CPRTCopart, Inc. -0.09%97.124.5%$173.21m
JCIJohnson Controls International Plc -0.11%41.001.4%$149.78m
ETSYEtsy, Inc. 1.06%51.448.0%$122.14m
LOPEGrand Canyon Education, Inc. 1.39%97.512.0%$88.59m
EFXEquifax, Inc. 1.34%153.052.0%$83.34m
TRUTransUnion 0.32%92.860.9%$71.39m
ITGartner, Inc. 0.18%161.212.4%$66.69m
PRAHPRA Health Sciences, Inc. -0.10%106.172.5%$62.99m
PAGSPagSeguro Digital Ltd. -0.50%36.000.0%$58.24m
BAHBooz Allen Hamilton Holding Corp. 0.54%79.422.0%$57.78m
CDAYCeridian HCM Holding, Inc. -0.08%72.760.0%$54.40m
BRBroadridge Financial Solutions, Inc. 1.29%131.021.5%$51.55m
CHGGChegg, Inc. 1.43%43.3315.7%$40.57m
BFAMBright Horizons Family Solutions, Inc. -0.28%162.221.4%$37.91m

Company Profile

OncoSec Medical, Inc. is a biotechnology company, which engages in designing, developing, and commercializing therapies for the treatment of cancer. Its lead product candidate, ImmunoPulse IL-12, uses an electroporation device, with the aim of reversing the immunosuppressive microenvironment in the treated tumor. The company was founded by Avtar S. Dhillon and Punit S. Dhillon on February 8, 2008 and is headquartered inPennington, NJ.